Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

Identifieur interne : 002227 ( Ncbi/Merge ); précédent : 002226; suivant : 002228

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

Auteurs : Shutoku Matsuyama [Japon] ; Noriyo Nagata ; Kazuya Shirato ; Miyuki Kawase ; Makoto Takeda ; Fumihiro Taguchi

Source :

RBID : pubmed:20926566

Descripteurs français

English descriptors

Abstract

The distribution of the severe acute respiratory syndrome coronavirus (SARS-CoV) receptor, an angiotensin-converting enzyme 2 (ACE2), does not strictly correlate with SARS-CoV cell tropism in lungs; therefore, other cellular factors have been predicted to be required for activation of virus infection. In the present study, we identified transmembrane protease serine 2 (TMPRSS2), whose expression does correlate with SARS-CoV infection in the upper lobe of the lung. In Vero cells expressing TMPRSS2, large syncytia were induced by SARS-CoV infection. Further, the lysosome-tropic reagents failed to inhibit, whereas the heptad repeat peptide efficiently inhibited viral entry into cells, suggesting that TMPRSS2 affects the S protein at the cell surface and induces virus-plasma membrane fusion. On the other hand, production of virus in TMPRSS2-expressing cells did not result in S-protein cleavage or increased infectivity of the resulting virus. Thus, TMPRSS2 affects the entry of virus but not other phases of virus replication. We hypothesized that the spatial orientation of TMPRSS2 vis-a-vis S protein is a key mechanism underling this phenomenon. To test this, the TMPRSS2 and S proteins were expressed in cells labeled with fluorescent probes of different colors, and the cell-cell fusion between these cells was tested. Results indicate that TMPRSS2 needs to be expressed in the opposing (target) cell membrane to activate S protein rather than in the producer cell, as found for influenza A virus and metapneumoviruses. This is the first report of TMPRSS2 being required in the target cell for activation of a viral fusion protein but not for the S protein synthesized in and transported to the surface of cells. Our findings suggest that the TMPRSS2 expressed in lung tissues may be a determinant of viral tropism and pathogenicity at the initial site of SARS-CoV infection.

DOI: 10.1128/JVI.01542-10
PubMed: 20926566

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20926566

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.</title>
<author>
<name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases, Japan, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan. matuyama@nih.go.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases, Japan, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nagata, Noriyo" sort="Nagata, Noriyo" uniqKey="Nagata N" first="Noriyo" last="Nagata">Noriyo Nagata</name>
</author>
<author>
<name sortKey="Shirato, Kazuya" sort="Shirato, Kazuya" uniqKey="Shirato K" first="Kazuya" last="Shirato">Kazuya Shirato</name>
</author>
<author>
<name sortKey="Kawase, Miyuki" sort="Kawase, Miyuki" uniqKey="Kawase M" first="Miyuki" last="Kawase">Miyuki Kawase</name>
</author>
<author>
<name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name>
</author>
<author>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20926566</idno>
<idno type="pmid">20926566</idno>
<idno type="doi">10.1128/JVI.01542-10</idno>
<idno type="wicri:Area/PubMed/Corpus">001614</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001614</idno>
<idno type="wicri:Area/PubMed/Curation">001614</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001614</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001683</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001683</idno>
<idno type="wicri:Area/Ncbi/Merge">002227</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.</title>
<author>
<name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases, Japan, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan. matuyama@nih.go.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases, Japan, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nagata, Noriyo" sort="Nagata, Noriyo" uniqKey="Nagata N" first="Noriyo" last="Nagata">Noriyo Nagata</name>
</author>
<author>
<name sortKey="Shirato, Kazuya" sort="Shirato, Kazuya" uniqKey="Shirato K" first="Kazuya" last="Shirato">Kazuya Shirato</name>
</author>
<author>
<name sortKey="Kawase, Miyuki" sort="Kawase, Miyuki" uniqKey="Kawase M" first="Miyuki" last="Kawase">Miyuki Kawase</name>
</author>
<author>
<name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name>
</author>
<author>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Blotting, Western</term>
<term>Chlorocebus aethiops</term>
<term>Fluorescent Antibody Technique</term>
<term>Giant Cells (metabolism)</term>
<term>Giant Cells (pathology)</term>
<term>Giant Cells (virology)</term>
<term>Humans</term>
<term>Lung (cytology)</term>
<term>Lung (metabolism)</term>
<term>Lung (virology)</term>
<term>Macaca fascicularis</term>
<term>Male</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>SARS Virus (pathogenicity)</term>
<term>Serine Endopeptidases (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (metabolism)</term>
<term>Virion (physiology)</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules Vero</term>
<term>Cellules géantes (anatomopathologie)</term>
<term>Cellules géantes (métabolisme)</term>
<term>Cellules géantes (virologie)</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Macaca fascicularis</term>
<term>Mâle</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Poumon (cytologie)</term>
<term>Poumon (métabolisme)</term>
<term>Poumon (virologie)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Serine endopeptidases (métabolisme)</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Syndrome respiratoire aigu sévère (métabolisme)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Technique d'immunofluorescence</term>
<term>Technique de Western</term>
<term>Virion (physiologie)</term>
<term>Virus du SRAS (pathogénicité)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Serine Endopeptidases</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Cellules géantes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Giant Cells</term>
<term>Lung</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cellules géantes</term>
<term>Glycoprotéines membranaires</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Poumon</term>
<term>Protéines de l'enveloppe virale</term>
<term>Serine endopeptidases</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Giant Cells</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Cellules géantes</term>
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Giant Cells</term>
<term>Lung</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Blotting, Western</term>
<term>Chlorocebus aethiops</term>
<term>Fluorescent Antibody Technique</term>
<term>Humans</term>
<term>Macaca fascicularis</term>
<term>Male</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules Vero</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Macaca fascicularis</term>
<term>Mâle</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Technique d'immunofluorescence</term>
<term>Technique de Western</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The distribution of the severe acute respiratory syndrome coronavirus (SARS-CoV) receptor, an angiotensin-converting enzyme 2 (ACE2), does not strictly correlate with SARS-CoV cell tropism in lungs; therefore, other cellular factors have been predicted to be required for activation of virus infection. In the present study, we identified transmembrane protease serine 2 (TMPRSS2), whose expression does correlate with SARS-CoV infection in the upper lobe of the lung. In Vero cells expressing TMPRSS2, large syncytia were induced by SARS-CoV infection. Further, the lysosome-tropic reagents failed to inhibit, whereas the heptad repeat peptide efficiently inhibited viral entry into cells, suggesting that TMPRSS2 affects the S protein at the cell surface and induces virus-plasma membrane fusion. On the other hand, production of virus in TMPRSS2-expressing cells did not result in S-protein cleavage or increased infectivity of the resulting virus. Thus, TMPRSS2 affects the entry of virus but not other phases of virus replication. We hypothesized that the spatial orientation of TMPRSS2 vis-a-vis S protein is a key mechanism underling this phenomenon. To test this, the TMPRSS2 and S proteins were expressed in cells labeled with fluorescent probes of different colors, and the cell-cell fusion between these cells was tested. Results indicate that TMPRSS2 needs to be expressed in the opposing (target) cell membrane to activate S protein rather than in the producer cell, as found for influenza A virus and metapneumoviruses. This is the first report of TMPRSS2 being required in the target cell for activation of a viral fusion protein but not for the S protein synthesized in and transported to the surface of cells. Our findings suggest that the TMPRSS2 expressed in lung tissues may be a determinant of viral tropism and pathogenicity at the initial site of SARS-CoV infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20926566</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>01</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>84</Volume>
<Issue>24</Issue>
<PubDate>
<Year>2010</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.</ArticleTitle>
<Pagination>
<MedlinePgn>12658-64</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01542-10</ELocationID>
<Abstract>
<AbstractText>The distribution of the severe acute respiratory syndrome coronavirus (SARS-CoV) receptor, an angiotensin-converting enzyme 2 (ACE2), does not strictly correlate with SARS-CoV cell tropism in lungs; therefore, other cellular factors have been predicted to be required for activation of virus infection. In the present study, we identified transmembrane protease serine 2 (TMPRSS2), whose expression does correlate with SARS-CoV infection in the upper lobe of the lung. In Vero cells expressing TMPRSS2, large syncytia were induced by SARS-CoV infection. Further, the lysosome-tropic reagents failed to inhibit, whereas the heptad repeat peptide efficiently inhibited viral entry into cells, suggesting that TMPRSS2 affects the S protein at the cell surface and induces virus-plasma membrane fusion. On the other hand, production of virus in TMPRSS2-expressing cells did not result in S-protein cleavage or increased infectivity of the resulting virus. Thus, TMPRSS2 affects the entry of virus but not other phases of virus replication. We hypothesized that the spatial orientation of TMPRSS2 vis-a-vis S protein is a key mechanism underling this phenomenon. To test this, the TMPRSS2 and S proteins were expressed in cells labeled with fluorescent probes of different colors, and the cell-cell fusion between these cells was tested. Results indicate that TMPRSS2 needs to be expressed in the opposing (target) cell membrane to activate S protein rather than in the producer cell, as found for influenza A virus and metapneumoviruses. This is the first report of TMPRSS2 being required in the target cell for activation of a viral fusion protein but not for the S protein synthesized in and transported to the surface of cells. Our findings suggest that the TMPRSS2 expressed in lung tissues may be a determinant of viral tropism and pathogenicity at the initial site of SARS-CoV infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Matsuyama</LastName>
<ForeName>Shutoku</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology III, National Institute of Infectious Diseases, Japan, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan. matuyama@nih.go.jp</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagata</LastName>
<ForeName>Noriyo</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shirato</LastName>
<ForeName>Kazuya</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kawase</LastName>
<ForeName>Miyuki</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takeda</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Taguchi</LastName>
<ForeName>Fumihiro</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>10</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="C421305">TMPRSS2 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015726" MajorTopicYN="N">Giant Cells</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012697" MajorTopicYN="N">Serine Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20926566</ArticleId>
<ArticleId IdType="pii">JVI.01542-10</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.01542-10</ArticleId>
<ArticleId IdType="pmc">PMC3004351</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2006 Feb 10;281(6):3198-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16339146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Jun 10;308(5728):1643-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15831716</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Struct Biol. 2006 Aug;155(2):176-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16697221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15010527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15140961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2008 Jun;172(6):1625-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18467696</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genomics. 1997 Sep 15;44(3):309-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9325052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Jpn J Infect Dis. 2005 Apr;58(2):88-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15858286</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Biochem Mol Biol. 2008 May-Jun;43(3):189-219</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18568847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2004 Jun;203(2):631-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15141377</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Jan;84(2):1198-205</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19864379</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Sep;82(17):8887-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18562523</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Mol Med. 2009 Jul;15(7):303-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19581128</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16081529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Aug;81(16):8722-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17522231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Sep;82(17):8942-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18562527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Jun;80(12):5768-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16731916</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2004 Jul;203(3):740-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15221932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Nov;83(21):11133-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19706706</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009;4(11):e7870</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19924243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 2008 Feb;52(2):118-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18380809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Oct;80(19):9896-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16973594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Jan;82(1):588-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17942557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Exp Pathol. 2007 Dec;88(6):403-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18039277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2003 Jul;200(3):282-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12845623</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Dec;82(23):11985-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18786990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Apr;80(8):4174-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16571833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2005 Aug;11(8):875-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16007097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Mar 8;277(10):8338-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11756432</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16116101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19321428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Apr;83(7):3200-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19158246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Sep 3;321(4):994-1000</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15358126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Genet Med. 2008 Nov 29;3(1):167-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19565019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Jpn J Infect Dis. 2008 Mar;61(2):157-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18362412</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
<region>
<li>Région de Kantō</li>
</region>
<settlement>
<li>Tokyo</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Kawase, Miyuki" sort="Kawase, Miyuki" uniqKey="Kawase M" first="Miyuki" last="Kawase">Miyuki Kawase</name>
<name sortKey="Nagata, Noriyo" sort="Nagata, Noriyo" uniqKey="Nagata N" first="Noriyo" last="Nagata">Noriyo Nagata</name>
<name sortKey="Shirato, Kazuya" sort="Shirato, Kazuya" uniqKey="Shirato K" first="Kazuya" last="Shirato">Kazuya Shirato</name>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
<name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name>
</noCountry>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002227 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002227 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:20926566
   |texte=   Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:20926566" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021